Security key
888705308
Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO)
CUSIP: 888705308
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 3,106,323
- Total 13F shares
- 21
- Share change
- +21
- Total reported value
- $54
- Price per share
- $2.58
- Number of holders
- 2
- Value change
- +$54
- Number of buys
- 2
Report period
Q1 2025
Institutions
2
Top holders
2
VBIO full security history
Newer quarter: Q2 2025
Valion Bio, Inc. SEC filings
Valion Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 888705308
Recent filing periods:
Top shareholders of VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| John Claude |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,196,000
|
— | — | 10 Nov 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
class O/S missing
|
58,658
|
$19,000 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
54,808
|
$18,964 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
47,981
|
$16,314 | — | 31 Dec 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
—
class O/S missing
|
38,568
|
$13,113 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
36,457
|
$12,394 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
18,884
|
$6,534 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
class O/S missing
|
12,147
|
$4,205 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
—
class O/S missing
|
306
|
$106 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
68
|
$24 | — | 31 Dec 2024 | |
| Blake Gurfein |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
235,000
mixed-class rows
|
— | — | 18 Dec 2024 | |
| Veronica Cai |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
117,880
|
— | — | 01 Apr 2022 | |
| Briana Benz |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
112,500
|
— | — | 10 Nov 2021 | |
| Ryan Sabia |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
100,000
|
— | — | 08 May 2023 | |
| Kimberly Ann Bambach |
3/4/5
|
Interim CFO |
—
class O/S missing
|
7,500
|
— | — | 01 Oct 2024 | |
| Karen Drexler |
3/4/5
|
Director |
—
class O/S missing
|
3,000
|
— | — | 30 Sep 2024 |
Institutional Holders of Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO) as of Q1 2025
As of 31 Mar 2025,
Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21 shares.
The largest 2 holders included
SBI Securities Co., Ltd. and BANK OF AMERICA CORP /DE/.
This page lists
2
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2025 Across Filers
Q4 2025 holders
7
Q1 2025 holders
2
Holder diff
-5
| Investor | Q4 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.